MarketBeat
18 Aug 2026, 05:03 UTC · 2h ago
TransMedics Targets $2B Opportunity With Kidney Push, European Expansion
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
18 Aug 2026, 05:03 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
TransMedics identifies a long-term revenue opportunity of over $2 billion, driven by a kidney program targeting up to 30,000 annual procedures. — A massive expansion into the kidney market represents a significant increase in the company's Total Addressable Market (TAM) and long-term valuation ceiling.
+0.80The company reiterated its annual revenue guidance of $737 million to $757 million, representing 22% to 25% growth. — Reconfirming guidance provides stability and confirms that current growth trajectories remain intact despite heavy investment spending.
+0.40TransMedics expects to reach or approach a 30% adjusted operating margin by 2028 or upon reaching 10,000 transplants. — Provides a clear profitability roadmap and a scale-based trigger for margin expansion, which is critical for high-growth medtech stocks.
+0.30Continue reading
6 related stories
Search tags
The acquisition of PAD Aviation allows TransMedics to bid on European transplant-logistics tenders worth tens of millions of euros. — Opens a new geographic revenue stream and scales the vertically integrated model into the European market.
+0.30The company is increasing investment spending in 2026, specifically for the OCS kidney program, which will keep 2026 operating margins between 12.5% and 14%. — Near-term margin compression due to higher CapEx/OpEx can create short-term headwinds for earnings per share.
-0.20Which stocks this story touches
Company reported strong revenue growth, profitability, and a clear strategic expansion plan into kidney transplantation and European markets.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
1h ago
